Gilead Sciences to Present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Daniel O’Day, Gilead’s Chairman and Chief Executive Officer, will provide an overview of the company at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13 at 9:30 a.m. Pacific Time.
The live webcast can be accessed at the company’s Investors page at http://investors.gilead.com . Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TX-MARY-KAY29.1.2020 15:02:05 CET | Press release
Mary Kay Continues Its Commitment to Skin Science Research in Its First Ever Partnership With International Master Course on Aging Science
NY-COTY-INC.29.1.2020 14:02:13 CET | Press release
Calvin Klein, Inc. and Calvin Klein Fragrances Announce CK ONE Underwear and Jeans and CK EVERYONE Fragrance
NY-MOODY’S-ANALYTICS29.1.2020 13:32:12 CET | Press release
Moody’s Analytics Tops Five Categories in CeFPro™ Fintech Leaders Report
JANSSEN29.1.2020 11:23:13 CET | Press release
Janssen Announces European Commission Approval for Expanded Use of Erleada®▼ (apalutamide) for Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer
CA-DOLE-FOOD-COMPANY-INC29.1.2020 11:00:05 CET | Press release
Dole Receives Social Responsibility Award from Costa Rican-North American Chamber of Commerce
CA-TEMENOS29.1.2020 10:07:03 CET | Press release
Temenos and Google Cloud Announce Global Strategic Partnership to Accelerate Banks’ Digital Transformation in the Cloud
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom